Concert Pharmaceuticals Inc. (CNCE) Rose 5.28% or 1.07 To Price $21.33 On Wednesday

Concert Pharmaceuticals Inc. (CNCE) rose 5.28% or 1.07 to $21.33. It is close to 223330 shares traded, which is 42.07% compare to the average total volume 530805. The market cap of CNCE is $485.74 million. The year to date change is -25.6%. The 52 week price range is from $9.01 to $30.71. Price of CNCE have changed -4.75% during last week. It have changed 5.30% over last month, 9.10% over last 3 months, 39.05% over last 6 months and 114.39% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CNCE is 23.62. It is 10.74% above current price. The 200-day Moving Averages for CNCE is 17.30. It is -18.89% below current price. The 52-week High is 30.71. It is 43.98% from the current price. The 52-week Low is 9.01. It is -57.76% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of CNCE is 1.57 on 2018-01-31. Short % to float is 4.54%. There are some statistics of CNCE. It is has market cap $485.74 million. The share outstanding is 22.77 million. The average volume is 530805. The revenue is 143.90M. The percent of top 15 Institution holding is 64.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CNCE is 61.41%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CNCE is 55.25%.


Share this post